A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Clinical trial NCT05012618 · TERMINATED

Trial details

NCT number: NCT05012618
Sponsor: Chugai Pharmaceutical
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors

Start date: 2021-10-08
Primary completion: 2025-11-13
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.